Medical Condition News

RSS

Valeant Pharmaceuticals receives Complete Response Letter from FDA for efinaconazole NDA

Valeant Pharmaceuticals International, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for efinaconazole for the treatment of onychomycosis.

28 May 2013

Research data on AMPYRA Extended Release Tablets to be presented at CMSC and ACTRIMS meeting

Acorda Therapeutics, Inc. will present new research data on AMPYRA (dalfampridine) Extended Release Tablets, 10 mg at the 5th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis, being held in Orlando, FL, May 29 - June 1.

28 May 2013

Alkermes reports positive results from phase 1 study of ALKS 3831 for treatment of schizophrenia

Alkermes plc today presented positive results from a phase 1 study of ALKS 3831, a novel drug candidate for the treatment of schizophrenia, in an oral session at the 53rd Annual New Clinical Drug Evaluation Unit Meeting in Hollywood, Fla.

28 May 2013

New study shows childhood bullying increases risk of self-harming in later adolescence

A new study has proven that being bullied during childhood directly increases the likelihood of self- harm in late adolescence.

28 May 2013

Asfotase alfa gets Breakthrough Therapy designation from FDA for treatment of patients with HPP

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to asfotase alfa for the treatment of patients with hypophosphatasia (HPP) whose first signs or symptoms occurred prior to 18 years of age, including perinatal-, infantile-, and juvenile-onset forms of the disease.

28 May 2013

Parachute's Safe Kids Week 2013: Be alert. Be safe. Be aware of concussions

Twelve-year-old Nathan Fraser suffered a severe concussion during hockey practice in February 2012 when he tripped over a teammate diving for a puck and crashed head first into the ice and boards. Nathan's memory was wiped out, he lost five months of school and was so sensitive to sound and light he had to wear sunglasses and special earmuffs in his own home. After a long, slow recovery, Nathan and his family are now advocates for concussion prevention and awareness, a goal of Parachute's Safe Kids Week, May 27 to June 2.

28 May 2013

Sorrento Therapeutics, IGDRASOL announce publication of clinical data for Cynviloq and gemcitabine

Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.

28 May 2013

Resolvins may help protect against cognitive decline after surgery

Resolvins are molecules naturally produced by the body from omega-3 fatty acids - a process that can be jumpstarted by common aspirin. In a new study, published in The FASEB Journal, researchers at Karolinska Institutet describe how resolvins could protect against the cognitive impairment that often affects recovery of surgical and critically ill patients.

28 May 2013

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Frutarom Health, Switzerland, reports increased demand for Go-Less, its natural ingredient targeting urinary incontinence in adults.

28 May 2013

New Smartphone app helps maintain accurate records to manage diabetes

Vital improvements can be made to patients diabetes control, by ensuring a recent blood glucose history is available to their Specialist Nurse. Traditionally patients have recorded their results in a paper logbook but now the new app from GlucoMen is a fantastic alternative using Smartphone technology to ensure a complete and accurate record.

28 May 2013

High comorbidity of DSM mood and anxiety disorders found among substance use disorder patients

Authors used both DSM-IV and DCPR criteria in a sample  of substance abuse outpatients to verify if DCPR might expand the psychological  assessment in SUD settings.

28 May 2013

Improved targeting of  depression treatment needed  in community settings

Relatively little is known about the prevalence and  correlates of over diagnosis of depression in community settings.

28 May 2013

DCPrime completes DCP-001 Phase I/IIa study in patients with acute myeloid leukemia

Cancer vaccine company DCPrime today announced the successful completion of its Phase I/IIa study in acute myeloid leukemia.

28 May 2013

Study reveals that an epilepsy drug shows promise in preventing noise-induced tinnitus

An epilepsy drug shows promise in an animal model at preventing tinnitus from developing after exposure to loud noise, according to a new study by researchers at the University of Pittsburgh School of Medicine.

28 May 2013

Findings support ongoing development, implementation of organized stroke care delivery

An integrated system of stroke care delivery in Ontario, Canada, has resulted in fewer deaths from stroke and fewer discharges to long-term care facilities because of better access to optimal stroke care, according to a study published in CMAJ (Canadian Medical Association Journal).

28 May 2013

New equations could shorten hospitalization for patients with uncontrolled pain, say researchers

For patients with uncontrolled pain from terminal cancer, a new approach to calculating initial dosage may allow a quicker start of spinal analgesia-and less time in the hospital, according to a study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

28 May 2013

Perceptual learning may hold promise for improving visual functions in people with central vision loss

Perceptual learning techniques may provide a useful new approach to rehabilitation in patients with central vision loss-taking advantage of visual plasticity that persists even in old age, according to a special article in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

28 May 2013

Exposure to bug or weed killers is associated with higher risk of Parkinson's disease

A large analysis of more than 100 studies from around the world shows that exposure to pesticides, or bug and weed killers, and solvents is likely associated with a higher risk of developing Parkinson's disease. The research appears in the May 28, 2013, print issue of Neurology-, the medical journal of the American Academy of Neurology.

28 May 2013

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin resistance.

28 May 2013

Researchers investigate preferences for participation in decision-making process among AMI patients

In a research letter, Harlan M. Krumholz, M.D., S.M., from Yale University School of Medicine and colleagues, "sought to investigate preferences for participation in the decision-making process among individuals hospitalized with an acute myocardial infarction ([AMI] or heart attack)."

28 May 2013

Medical Condition News

Valeant Pharmaceuticals receives Complete Response Letter from FDA for efinaconazole NDA

Research data on AMPYRA Extended Release Tablets to be presented at CMSC and ACTRIMS meeting

Alkermes reports positive results from phase 1 study of ALKS 3831 for treatment of schizophrenia

New study shows childhood bullying increases risk of self-harming in later adolescence

Asfotase alfa gets Breakthrough Therapy designation from FDA for treatment of patients with HPP

Parachute's Safe Kids Week 2013: Be alert. Be safe. Be aware of concussions

Sorrento Therapeutics, IGDRASOL announce publication of clinical data for Cynviloq and gemcitabine

Resolvins may help protect against cognitive decline after surgery

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

New Smartphone app helps maintain accurate records to manage diabetes

High comorbidity of DSM mood and anxiety disorders found among substance use disorder patients

Improved targeting of  depression treatment needed  in community settings

DCPrime completes DCP-001 Phase I/IIa study in patients with acute myeloid leukemia

Study reveals that an epilepsy drug shows promise in preventing noise-induced tinnitus

Findings support ongoing development, implementation of organized stroke care delivery

New equations could shorten hospitalization for patients with uncontrolled pain, say researchers

Perceptual learning may hold promise for improving visual functions in people with central vision loss

Exposure to bug or weed killers is associated with higher risk of Parkinson's disease

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Researchers investigate preferences for participation in decision-making process among AMI patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News